318
Participants
Start Date
June 28, 2007
Primary Completion Date
January 2, 2008
Study Completion Date
January 2, 2008
Vyvanse (lisdexamfetamine dimesylate)
Vyvanse™ 20mg once daily at 7 a.m.; dose increased weekly by 10mg until an acceptable response is achieved. Titration may proceed to a maximum daily dose 70mg/day.
Melmed Center, Scottsdale
Valley Clinical Research, El Centro
Peninsula Research Assoc, Inc, Rolling Hills Estates
UCSF-Langely Porter Psych Institute, San Francisco
Encompass Clinical Research, Spring Valley
Shire Clinical Research Site, Wildomar
Sarkis Clinical Trials, Gainesville
Shire Clinical Research Site, Hialeah
CNS Research Institute, Inc, Jacksonville
CORE Research, Inc, Maitland
Miami Research Associates, Miami
Clinical Neuroscience Solutions, Inc, Orlando
Janus Center for Psychiatric Research, West Palm Beach
Children's Development Center, Winter Park
Capstone Clinical Research, Libertyville
Indiana University School of Medicine, Indianapolis
Shire Clinical Research Site, Terre Haute
Shire Clinical Research Site, Newton
Psychiatric Associates, Overland Park
Kentucky Pediatric/Adult Research, Bardstown
Shire Clinical Research Site, Lexington
Pedia Research, Owensboro
Four Rivers Clinical Research, Inc., Paducah
Shire Clinical Research Site, Troy
University of Rochester, School of Medicine and Dentistry, Rochester
Piedmont Neuropsychiatry, Charlotte
University Commons Office Park, Durham
University Hospitals of Cleveland, Cleveland
BHI, Inc., Moore
Shire Clinical Research Site, Oklahoma City
Oregon Center for Clinical Investigations, Inc, Eugene
Oregon Center For Clinical Investigations, Inc., Portland
Summit Research Network, Portland
Oregon Center for Clinical Investigations, Inc., Salem
ADHD Program, Western Psychiatric Institute and Clinic, Pittsburgh
The Jackson Clinic, Jackson
Clinical Neuroscience Solutions, Inc, Memphis
FutureSearch Trials, Austin
Claghorn-Lesem Research Clinic Inc., Bellaire
Red Oak Psychiatry Associates P.A., Houston
R/D Clinical Research, Inc., Lake Jackson
ADHD Clinic of San Antonio, San Antonio
NeuroScience, Inc, Herndon
Dominion Clinical Research, Midlothian
International Clinical Research Associates, LLC, Richmond
Eastside Therapeutic Resource, Kirkland
Lead Sponsor
Shire
INDUSTRY